CWAF
SLS icon

Core Wealth Advisors (Florida)’s SELLAS Life Sciences SLS Stock Holding History

Core Wealth Advisors (Florida)’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30
Closed – – 204
2021
Q1 		$0 Buy
+30
New +$245 ﹤0.01% 202

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EH
Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Core Wealth Advisors (Florida)'s SLS Position: Q2 2021 in Review

Core Wealth Advisors (Florida) sold out of SELLAS Life Sciences (SLS) in Q2 2021, closing a stake of 30 shares.

Core Wealth Advisors (Florida) first reported a position in SLS in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 29 funds tracked by Wall St. Rank hold SLS as of Q2 2021.

  • Core Wealth Advisors (Florida) reported no remaining SELLAS Life Sciences position as of Q2 2021 after selling out during the quarter.
  • Core Wealth Advisors (Florida) sold 30 SELLAS Life Sciences shares in Q2 2021.
  • Core Wealth Advisors (Florida) first reported a position in SELLAS Life Sciences in Q1 2021 and held it in 1 quarter.
  • Core Wealth Advisors (Florida)'s SELLAS Life Sciences position peaked at $0 in Q1 2021.
  • 29 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2021.

Based on Core Wealth Advisors (Florida)'s 13F filing for Q2 2021, filed 3 Aug 2021.